Torsemide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 595 publications

Intrarenal Determinants of GFR Decline During Loop Diuretic Therapy.

Intrarenal Determinants of GFR Decline During Loop Diuretic Therapy.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: August 31, 2026

In symptomatic HF, sacubitril-valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo.

In symptomatic HF, sacubitril-valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo.

Journal: Annals of internal medicine

Published: August 03, 2026

Lost to Follow-Up in Pragmatic Trials With Remote Follow-Up: Insights From CONNECT-HF and TRANSFORM-HF.

Lost to Follow-Up in Pragmatic Trials With Remote Follow-Up: Insights From CONNECT-HF and TRANSFORM-HF.

Journal: Journal of the American Heart Association

Published: July 25, 2026

From Golden Berry To Golden Nanoprobe: Sustainable Fluorescent Sensing of Torsemide For Doping Control in Athletes.

From Golden Berry To Golden Nanoprobe: Sustainable Fluorescent Sensing of Torsemide For Doping Control in Athletes.

Journal: Journal of fluorescence

Published: June 23, 2026

Severe Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome Successfully Managed With Transvenous Pacing and Continuous Renal Replacement Therapy.

Severe Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome Successfully Managed With Transvenous Pacing and Continuous Renal Replacement Therapy.

Journal: Cureus

Published: June 05, 2026

Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure.

Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure.

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

Published: April 28, 2026

Diuretic Resistance Risk and the Efficacy of Torsemide vs Furosemide: A Post-Hoc Analysis of the TRANSFORM-HF Trial.

Diuretic Resistance Risk and the Efficacy of Torsemide vs Furosemide: A Post-Hoc Analysis of the TRANSFORM-HF Trial.

Journal: European journal of heart failure

Published: April 12, 2026

In brief: A bumetanide nasal spray (Enbumyst) for edema.

In brief: A bumetanide nasal spray (Enbumyst) for edema.

Journal: The Medical letter on drugs and therapeutics

Published: April 10, 2026

Comparing Ibuprofen and Loop Diuretics for Protein-Bound Uremic Toxins Clearance During Hemodialysis.

Comparing Ibuprofen and Loop Diuretics for Protein-Bound Uremic Toxins Clearance During Hemodialysis.

Journal: Kidney international reports

Published: April 09, 2026

Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: win-ratio reanalysis of the TRANSFORM-HF trial.

Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: win-ratio reanalysis of the TRANSFORM-HF trial.

Journal: American heart journal

Published: April 02, 2026

Real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, multicenter, observational study.

Real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, multicenter, observational study.

Journal: Therapeutic advances in cardiovascular disease

Published: March 17, 2026

In brief: A second subcutaneous furosemide infusor (Lasix ONYU) for heart failure.

In brief: A second subcutaneous furosemide infusor (Lasix ONYU) for heart failure.

Journal: The Medical letter on drugs and therapeutics

Published: March 07, 2026

Showing 1-12 of 595

Last Updated: 09/26/2026